Transcript
Page 1: Screening Methods of Antihypertensive Agents

Preclinical screening methods of Antihypertensive agents

(for MD Pharmacology)

- Dr. Advaitha M V

Page 2: Screening Methods of Antihypertensive Agents

Introduction • The animal models of hypertension share many

features which are common to human hypertension.

• Many of these models have been developed by utilizing the etiological factors that are presumed to be responsible for human hypertension.

Excessive salt intake.

Hyperactivity of renin-angiotensin- aldosteronesystem (RAAS) and

Genetic factors.

Page 3: Screening Methods of Antihypertensive Agents

An ideal animal model of hypertension criteria

• It should be feasible in small animals.

• Simple to perform and uniformly reproducible.

• Should be able to predict the potential antihypertensive properties of an agent.

• Consume minimal quantities of compounds.

• It should be comparable to some form of human hypertension.

Page 4: Screening Methods of Antihypertensive Agents
Page 5: Screening Methods of Antihypertensive Agents
Page 6: Screening Methods of Antihypertensive Agents

Animals used

• In the past, most studies

on experimental hypertension were carried out on Dogs.

• Currently, rat is the preferred animal species.

• Spontaneous hypertensive rat (SHR), the genetic strain of hypertensive rat, is the animal of choice.

Page 7: Screening Methods of Antihypertensive Agents

Types of animal models of hypertension

1. Renovascular hypertension

2. Dietary hypertension

3. Endocrine hypertension

4. Neurogenic hypertension

5. Psychogenic hypertension

6. Genetic hypertension

7. Other models

Page 8: Screening Methods of Antihypertensive Agents

1. Renovascular Hypertension

Page 9: Screening Methods of Antihypertensive Agents

• This is a very commonly used model of hypertension.

• Experimentally, renal hypertension is produced by constriction of renal artery.

• This activates peripheral RAAS and sympathetic nervous system.

Page 10: Screening Methods of Antihypertensive Agents
Page 11: Screening Methods of Antihypertensive Agents

Methods of inducing renovascularhypertension

Goldblatt method:

Goldblatt et al (1934)

• He reported that a partial constriction of renal arteries in dogs produced hypertension.

• This type of hypertension has also been induced in rabbits, rats and monkeys.

Page 12: Screening Methods of Antihypertensive Agents

• Rats weighing from 120 to 200 g are anaesthetized with hexobarbitone sodium (40 mg/kg body weight).

• A silver clip of 0.2 mm internal diameter is placed on the left renal artery close to the aorta.

• The renal artery in rats can also be ligatedwith 4-0 silk suture.

Page 13: Screening Methods of Antihypertensive Agents

• Constriction of renal artery should be more than 50%.

• The animal is considered hypertensive if systolic BP is more than 160 mm Hg for two consecutive days after 4 weeks of ligation/application of clip.

Page 14: Screening Methods of Antihypertensive Agents

• Three variants of hypertension produced by Goldblatt method-

• Two kidney one clip (2K1C) hypertension

• One kidney one clip (1K1C) hypertension

• Two kidney two clip (2K2C) hypertension

Page 15: Screening Methods of Antihypertensive Agents

Two kidney one clip (2K1C) hypertension

• The renal artery is constricted on only one side with the other artery (or kidney) left untouched.

• This results in a sustained increase in BP.

• Initially , there is no salt and water retention because of the other normal kidney being intact.

• So , the resultant hypertension at this stage is renin-angiotensin dependent.

Page 16: Screening Methods of Antihypertensive Agents

• After about 6 weeks, the increased angiotensin-II releases aldosterone from adrenal cortex leading to gradual retention of salt and water.

• Retention of salt and water leads to decreased renin production.

• From this stage onwards, hypertension is volume dependent.

Page 17: Screening Methods of Antihypertensive Agents

One kidney one clip (1K1C) hypertension

• Constriction of renal artery is done on one side and the contra lateral kidney is removed.

• There is an increase in BP within a few hours.

• Since there is no contra lateral kidney, there is no pressure diuresis and natriuresis.

Page 18: Screening Methods of Antihypertensive Agents

• So there is rapid salt and water retention.

• Plasma renin activity is usually normal.

• Hypertension soon becomes volume dependent

Page 19: Screening Methods of Antihypertensive Agents

Two kidney two clip (2K2C) hypertension

• Constriction of aorta or both renal arteries is done.

• There is a patchy ischemic kidney tissue, which secretes renin leading to increased BP.

• The remaining kidney tissue retains salt and water.

• one of the most common causes of renal hypertension in human beings is (such) a patchy ischaemic kidney disease.

Page 20: Screening Methods of Antihypertensive Agents

Hypertension induced by external compression of renal parenchyma

Grollman hypertension

• In this method, kidney tissue is compressed by securing a 'figure of 8' ligature.

• It is of two types:

• Two kidney one ligature (2K1L)

• One kidney one ligature (1K1L)

Page 21: Screening Methods of Antihypertensive Agents

Reduced renal mass

• Reducing renal tissue to five-sixth (5/6th) by renal mass ablation produces hypertension.

• Here , the right kidney is removed and 2 or 3 branches of left renal artery are ligated.

• This is to produce infarction of approximately 2/3rd of the left kidney.

Page 22: Screening Methods of Antihypertensive Agents

2. Dietary hypertension:

Page 23: Screening Methods of Antihypertensive Agents

I. Increased salt intake:

• Chronic ingestion of excess salt produces hypertension in rats, which mimics human hypertension morphologically.

• High salt intake hypertension has been produced in rats, rabbits and chicks by replacing drinking water with 1-2% sodium chloride for 9-12 months.

Page 24: Screening Methods of Antihypertensive Agents

• This method is also used to cause Accelerated high pressure in renal hypertension.

Page 25: Screening Methods of Antihypertensive Agents

3. Endocrine hypertension

Page 26: Screening Methods of Antihypertensive Agents

DOCA-Salt induced HTN

• Selye et al was the first to demonstrate that deoxycorticosterone acetate (DOCA) produces hypertension in rats.

• There is increased DOCA-induced reabsorption of salt and water leading to increased blood volume and hence increased BP.

• There is also increased secretion of vasopressin leading to water retention and vasoconstriction.

Page 27: Screening Methods of Antihypertensive Agents

• In addition, altered activity of RAAS leads to increased sympathetic activity

• Rats, especially female and young, are prone to DOCA-salt induced hypertension.

• DOCA induced hypertension is salt dependent

(neither administration of DOCA nor partial removal of renal mass is effective in increasing BP when applied without salt Administration).

Page 28: Screening Methods of Antihypertensive Agents

To produce hypertension,

• Rats weighing about 100 g are kept on a diet high in sodium chloride and drinking water is replaced by 2% sodium chloride solution.

• After they attain a weight of about 250 g, they are given DOCA dissolved in sesame seed oil at a dose of 10 mg/kg SC, twice weekly for 4 weeks.

Page 29: Screening Methods of Antihypertensive Agents

4. Neurogenic hypertension

Page 30: Screening Methods of Antihypertensive Agents

• One of the most important negative feedback in the control of BP originates from baroreceptorsin the carotid sinus and aortic arch.

• Afferents of baroreceptors travel along 9th and 10th cranial nerves.

• Sectioning of the baroreceptor nerves leads to persistent rise in BP.

• Suitable in dogs, cats and rabbits

Page 31: Screening Methods of Antihypertensive Agents

5. Psychogenic hypertension

Page 32: Screening Methods of Antihypertensive Agents

• Repeated exposure to stressful situation may lead to a state of persistent hypertension.

• Borderline hypertensive rats (BHR) are useful for psychogenic hypertension.

• BHRs that were exposed to daily sessions of either short (20 min) or long (120 min) duration air-jet stimulation developed hypertension within 2 weeks.

Page 33: Screening Methods of Antihypertensive Agents

• Stress plays an important part in development of human hypertension.

• So, This model is also very frequently used to study the pathophysiology of hypertension.

Page 34: Screening Methods of Antihypertensive Agents

6. Genetic hypertension

Page 35: Screening Methods of Antihypertensive Agents

• The so called ‘spontaneous hypertensive rat (SHR)’ was developed by meticulous genetic inbreeding by Okamoto and Aoki.

• This inbreeding resulted in 100% of the progeny having naturally occurring hypertension

Page 36: Screening Methods of Antihypertensive Agents

How are SHR ?

• In SHRs, BP gradually increases until it is maintained at a markedly elevated level after approximately 12 weeks of age.

• In unrestrained male SHRs, mean arterial pressure is approximately 190- 200 mm Hg as compared to 115-130 mm Hg in normal rats.

Page 37: Screening Methods of Antihypertensive Agents

• During the early stable stages and developmental phase of hypertension-

elevated BP is maintained in large part by enhanced central sympathetic outflow.

• In the later stages

Increased total peripheral resistance.

normal cardiac output

decreased permeability of the glomerularmembranes

Forms the basis for the long term maintenance of the hypertension

Page 38: Screening Methods of Antihypertensive Agents

• SHRs also develop typical complications of hypertension.

• There are Stroke prone SHRs (SHRSP), which are selectively bred among SHRs.

• These develop cerebrovascular lesions spontaneously in over 80% of rats.

Page 39: Screening Methods of Antihypertensive Agents

• Because of apparent similarities of the SHR to essential hypertension-

SHR models are highly recommended for screening potential drug candidates for hypertension

Page 40: Screening Methods of Antihypertensive Agents

• Other models

Page 41: Screening Methods of Antihypertensive Agents

Obesity-related hypertension

• Wistar fatty rats (WFR) are derived from cross between obese Zucker and Wistar Kyoto rats.

• These show persistent hyperinsulinemia and hypertension after 16 weeks of age.

• A good model to elucidate the relationship between hyperinsulinemia and hypertension.

Page 42: Screening Methods of Antihypertensive Agents
Page 43: Screening Methods of Antihypertensive Agents

Wistar Kyoto Rat

Page 44: Screening Methods of Antihypertensive Agents

Transgenic rat (TGR) models• Transgenic models of hypertension have

revolutionized the experimental work on hypertension.

• Here , an additional renin gene, the murineRen-2 gene, is introduced into the germ line of rats.

• This results in transgenic hypertensive rat strain, TGR (mREN2).

• It has an overexpression of renin.

Page 45: Screening Methods of Antihypertensive Agents

• Linkage has been described for the angiotensinogen gene in human hypertension.

• TGR model are also useful for studying the role of local RAAS system in hypertension.

Page 46: Screening Methods of Antihypertensive Agents

Others

• Angiotensin-II induced hypertension.

• Hypertension induced by cadmium

• Chronic nitric oxide inhibition-induced hypertension.

Page 47: Screening Methods of Antihypertensive Agents
Page 48: Screening Methods of Antihypertensive Agents

How to measure BP ?

Direct Method :

• It is a invasive procedure.

• A week before the drug adminstration, The animals are anesthetized.

• Femoral/Carotid Cannula is inserted.

• On the day of screening, cannula is connected to a mercury manometer or a pressure transducer.

• BP is measured

Page 49: Screening Methods of Antihypertensive Agents

In rats

• A week before the experiment, each rat is anaesthetised with 40 mg/kg pentobarbital.

• Left or right carotid artery or femoral artery is cannulated under aseptic conditions with polyethylene cannula filled with 1% heparin in normal saline.

• Free end of the cannula is passed under the skin and allowed to protrude 3-4 cm from the skin behind the ears of the rat.

Page 50: Screening Methods of Antihypertensive Agents

• The skin incisions are sutured and a plastic skin dressing is applied.

• After recovery from anaesthesia (2-2.5 h) each rat is placed in an individual cage for 24 h habituation period

Page 51: Screening Methods of Antihypertensive Agents

• On the day of expt., Cannula is connected to a pressure transducer then to the pre-amplifier.

• BP is recorded on the polygraph or physiograph.

Page 52: Screening Methods of Antihypertensive Agents

Non-Invasive/ Indirect method :

In rats

Tail cuff Method :

• It is a common and convenient method.

• Tail cuff is inflated and then deflated.

• Pulsations disappear when cuff is inflated.

• When cuff is deflated, pulsations start appearing when pressure in the cuff equals systolic pressure.

Page 53: Screening Methods of Antihypertensive Agents
Page 54: Screening Methods of Antihypertensive Agents
Page 55: Screening Methods of Antihypertensive Agents

• The cuff is attached to a tail cuff sphygmomano-meter or pressure transducer and BP is recorded on a chart.

• Tail swelling method.

• Foot swelling method.

Page 56: Screening Methods of Antihypertensive Agents

Effects of antihypertensive agents

• Antihypertensive drugs, according to their mode of action, will affect the blood pressure in certain types of experimental hypertension, and not in all !

• Vasodilators like minoxidil, hydralazine and diazoxide are effective in renal hypertensive rats.

Page 57: Screening Methods of Antihypertensive Agents

• CCB, ACE inhibitors and AT-1 antagonists decrease BP in 5/6 nephrectomised SHR

• Diuretics, are active in mineralocorticoid or salt induced hypertension.

• Sympathomimetic Drugs decrease BP in both endocrine and neurogenic hypertension.

Page 58: Screening Methods of Antihypertensive Agents

An E.g. of data collection

Page 59: Screening Methods of Antihypertensive Agents

Invitro models

• Endocrine receptor antagonism in porcine isolated heart

• Monocrantaline-induced pulmonary hypertension.

Page 60: Screening Methods of Antihypertensive Agents

References • D.K. BADYAL, H. LATA , A.P. DADHICH. ANIMAL MODELS OF

HYPERTENSION AND EFFECT OF DRUGS. Indian Journal of Pharmacology 2003; 35: 349-362.

• Journal of Visualized Experiments videos

Video downloads from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794298/bin/jove-27-1291.flv

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462562/bin/jove-59-3496.mov

Page 61: Screening Methods of Antihypertensive Agents

Thank You


Top Related